Showing results (221-230 of 253) with videos related to
Sort By:
Pageof 26
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 27, 2004
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and childrenAliya A Khan, Laura Bachrach, Jacques P Brown, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practiceDidier B Hans, John A Kanis, Sanford Baim, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 29, 2024
Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024Felicia Cosman, E Michael Lewiecki, Richard Eastell, et al.The Journal of Clinical Endocrinology and Metabolism|June 16, 2012
Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trialDavid W Dempster, Hua Zhou, Robert R Recker, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 4, 2016
A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ TrialDavid W Dempster, Hua Zhou, Robert R Recker, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2016
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for OsteoporosisSteven R Cummings, Felicia Cosman, E Michael Lewiecki, et al.Mayo Clinic Proceedings|July 3, 2024
Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best PracticesAliya A Khan, Riemer H J A Slart, Dalal S Ali, et al.The Journal of Clinical Endocrinology and Metabolism|January 22, 2015
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trialBente L Langdahl, Christence Stubbe Teglbjærg, Pei-Ran Ho, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|August 4, 2011
Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®E Michael Lewiecki, Juliet E Compston, Paul D Miller, et al.The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral densityEric Orwoll, Christence S Teglbjærg, Bente L Langdahl, et al.Pageof 26